Mecasermin Completed Phase 3 Trials for Insulin-Like Growth Factor-1 Deficiency / Growth Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00125164Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency